These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26489674)

  • 41. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer.
    Luo Y; Qin SL; Mu YF; Wang ZS; Zhong M; Bian ZQ
    Biomed Pharmacother; 2015 Jul; 73():135-9. PubMed ID: 26211594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas.
    Han SL; Wu XL; Wan L; Zeng QQ; Li JL; Liu Z
    Dig Surg; 2009; 26(2):156-62. PubMed ID: 19365123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.
    Qiao J; Fang CY; Chen SX; Wang XQ; Cui SJ; Liu XH; Jiang YH; Wang J; Zhang Y; Yang PY; Liu F
    Oncotarget; 2015 Oct; 6(30):29929-46. PubMed ID: 26338966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
    Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathologic study and outcome analysis of thyroid lymphomas: experience from a tertiary cancer center.
    Katna R; Shet T; Sengar M; Menon H; Laskar S; Prabhash K; D'Cruz A; Nair R
    Head Neck; 2013 Feb; 35(2):165-71. PubMed ID: 22368156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
    Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
    Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.
    De Silva P; Garaud S; Solinas C; de Wind A; Van den Eyden G; Jose V; Gu-Trantien C; Migliori E; Boisson A; Naveaux C; Duvillier H; Craciun L; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
    EBioMedicine; 2019 Jan; 39():226-238. PubMed ID: 30579865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel epigenetic regulation of circFoxp1 on Foxp1 in colon cancer cells.
    Luo Y; Liu F; Ma J; Fu Y; Gui R
    Cell Death Dis; 2020 Sep; 11(9):782. PubMed ID: 32951006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement.
    Barrans SL; Fenton JA; Ventura R; Smith A; Banham AH; Jack AS
    Haematologica; 2007 Jun; 92(6):863-4. PubMed ID: 17550867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene Expression Profiling of Head and Neck Tumors Identifies FOXP1 and SOX10 Expression as Useful for Distinguishing Ameloblastoma From Basaloid Salivary Gland Tumors.
    Ko YCK; Varma S; Zhu CF; Zhu SX; Vennam S; Poh CF; Jordan RC; Kong C; Pollack JR; West RB
    Am J Surg Pathol; 2020 May; 44(5):665-672. PubMed ID: 31895100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical expression analysis of leucine-rich PPR-motif-containing protein (LRPPRC), a candidate colorectal cancer biomarker identified by shotgun proteomics using iTRAQ.
    Nishio T; Kurabe N; Goto-Inoue N; Nakamura T; Sugimura H; Setou M; Maekawa M
    Clin Chim Acta; 2017 Aug; 471():276-282. PubMed ID: 28622966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.
    Oskay Halacli S
    Cell Biol Int; 2017 Jan; 41(1):102-110. PubMed ID: 27859969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer.
    Melling N; Simon R; Mirlacher M; Izbicki JR; Stahl P; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Histopathology; 2016 Jan; 68(2):191-8. PubMed ID: 25922889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The high expression of FOXE1 in colorectal cancer predicts a promising prognosis: a retrospective study.
    Liu X; Chen L; Wen F; Zheng S; Ge W
    Clin Exp Med; 2023 Nov; 23(7):3995-4001. PubMed ID: 37278933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients.
    Pallante P; Terracciano L; Carafa V; Schneider S; Zlobec I; Lugli A; Bianco M; Ferraro A; Sacchetti S; Troncone G; Fusco A; Tornillo L
    Eur J Cancer; 2010 Aug; 46(12):2304-13. PubMed ID: 20542683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FoxP1 orchestration of ASD-relevant signaling pathways in the striatum.
    Araujo DJ; Anderson AG; Berto S; Runnels W; Harper M; Ammanuel S; Rieger MA; Huang HC; Rajkovich K; Loerwald KW; Dekker JD; Tucker HO; Dougherty JD; Gibson JR; Konopka G
    Genes Dev; 2015 Oct; 29(20):2081-96. PubMed ID: 26494785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole genome sequencing identifies a de novo 2.1 Mb balanced paracentric inversion disrupting FOXP1 and leading to severe intellectual disability.
    Vuillaume ML; Cogné B; Jeanne M; Boland A; Ung DC; Quinquis D; Besnard T; Deleuze JF; Redon R; Bézieau S; Laumonnier F; Toutain A
    Clin Chim Acta; 2018 Oct; 485():218-223. PubMed ID: 29969624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastrointestinal dysfunction in autism displayed by altered motility and achalasia in
    Fröhlich H; Kollmeyer ML; Linz VC; Stuhlinger M; Groneberg D; Reigl A; Zizer E; Friebe A; Niesler B; Rappold G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22237-22245. PubMed ID: 31611379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FOXP1 inhibits pancreatic cancer growth by transcriptionally regulating IRF1 expression.
    Wang L; Luo P; Yang Z; Zhong X; Ji C
    PLoS One; 2023; 18(3):e0280794. PubMed ID: 36952469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role.
    Bullock MD; Bruce A; Sreekumar R; Curtis N; Cheung T; Reading I; Primrose JN; Ottensmeier C; Packham GK; Thomas G; Mirnezami AH
    Br J Cancer; 2013 Jul; 109(2):387-94. PubMed ID: 23828518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.